Novo Nordisk’s majority shareholder Novo Holdings is buying Catalent for $16.5 billion, and then selling the three fill-and-finish facilities in the US, Belgium, and Italy to Novo Nordisk for ...
The takeover also means that a related $11 billion transaction in which Novo Holdings' subsidiary Novo Nordisk takes control of three of Catalent’s fill-and-finish facilities in Italy ...
Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Copyright © 2025 BBC. The BBC is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback